Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism

Thyroid

Volumn 9, Issue 2, 1999, Pages 189-192

  Burmeister, Lynn A ^a   Beatty, Randall L ^a   Wall, Jack R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; RADIOACTIVE IODINE;

ADULT; ARTICLE; CASE REPORT; CHALAZION; CORTICOSTEROID THERAPY; DIAGNOSTIC ERROR; EXOPHTHALMOS; FEMALE; GRAVES DISEASE; HUMAN; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; TREATMENT PLANNING;

EID: 0032967789     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.189     Document Type: Article

References (30)

1. Kubota S, Gunji K, Ackrell B, Cochran B, Stolarski C, Wengrowicz S, Kennerdell J, Hiromatsu Y, Wall J 1998 The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab 83:443-447.
2. Miller A, Sikorska H, Salvi M, Wall J 1986 Evaluations of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy. Acta Endocrinol 113:514-522.
3. Kapusta M, Salvi M, Triller H, Gardini E, Bernard N, Wall J 1990 Eye muscle membrane reactive antibodies are not detected in the serum of immunoglobulin fraction of patients with thyroid-associated ophthalmopathy using an ELISA and crude membranes. Autoimmunity 7:33-40.
4. Vestergaard H, Laurberg P 1989 Radioiodine and aggravation of Graves' ophthalmopathy. Lancet 2:47.
5. Hamilton R, Mayberry W, McConahey W, Hanson K 1967 Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodide. Mayo Clin Proc 42:812-818.
6. 131I therapy. Proc Ros Soc Med 62:15-18.
7. Barbosa J, Wong E, Doe R 1972 Ophthalmopathy of Graves' disease. Outcome after treatment with radioactive iodine, surgery, or antithyroid drugs. Arch Intern Med 130:111-113.
8. Gwinup G, Elias A, Ascher M 1982 Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 247:2135-2138.
9. Calissendorff B, Söderström M, Alveryd A 1986 Ophthalmopathy and hyperthyroidism, a comparison between patients receiving different antithyroid treatments. Acta Opthalmol 64:698-703.
10. Sridama V, DeGroot L 1989 Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 87:70-73.
11. Karlsson F, Dahlberg P, Jansson, Westermark K, Enoksson P 1989 Importance of TSH receptor activation in the development of severe endocrine ophthalmopathy. Acta Endocrinol Suppl 121:132-141.
12. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A 1992 Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 2:171-178.
13. Vázquez-Chávez C, Nishimura-Meguro E, Espinosa-Said L, Delgado-Falfari A, Sáinz-de-Viteri M 1992 Influencia del tratamiento del hipertiroidismo en el curso del exoftalmos. Rev Inv Clin 44:241-247.
14. Fernández-Sánche J, Paradas JR, Marinez OC, Vela ET, Jimenez FE, Juentes IG, Thorbeck RV 1993 Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 80:1134-1136.
15. Kung A, Yau C, Cheng S 1994 The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: Prognostic factors and the role of methimazole. J Clin Endocrinol Metab 79:542-546.
16. Manso P, Furlanetto R, Wolosker A, Paiva E, de-Abreu M, Maciel R 1998 Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism. Thyroid 8:49-52.
17. Tallstedt L, Lundell G, Tørring O, Wallin G, Ljunggren J, Blomgren H, Taube A 1992 Occurrence of opthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
18. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda M, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei M, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of graves' ophthalmopathy. N Engl J Med 338:73-78.
19. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1352.
20. Barth A, Probst P, Bürgi H 1991 Identification of a subgroup of Graves' disease patients at higher risk for severe opthalmopathy after radioiodine. J Endocrinol Invest 14:209-212.
21. Bartley G, Fatourechi V, Kadrmas E, Jacobsen S, Ilstrup D, Garrity J, Gorman C 1996 The chronology of Graves' ophthalmopathy in an incidence cohort. Am J Opthalmology 121:426-434.
22. Villadolid M, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, Kiriyama T, Uetani M, Nagataki S 1995 Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle enlargement by magnetic resonance. J Clin Endocrinol Metab 80:2830-2833.
23. Winsa B, Mandahl A, Karlsson F 1993 Graves' disease, endocrine ophthalmopathy and smoking. Acta Endocrinol 128:156-160.
24. Berttelsen J, Hegedüs L 1994 Cigarette smoking and the thyroid. Thyroid 4:327-331.
25. Shine B, Fells P, Edwards O, Weetman A 1990 Graves' ophthalmopathy is associated with smoking. Lancet 335: 1261-1263.
26. Prummel M, Wiersinga W, Mourits M, Koorneef L, Berghout A, Gaag Rvd 1990 Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 150:1098-1101.
27. Atkinson S, McGregor A, Kendall-Taylor P, Peterson M, Smith B 1982 Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clin Endocrinol 16:537-543.
28. Macchia E, Concetti R, Borgoni F, Cetani F, Fenzi G, Pinchera A 1989 Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: Their incidence, significance and clinical usefulness. Autoimmunity 3:103-112.
29. Ilicki A, Gamstedt A, Karlsson F 1992 Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 74:1090-1094.
30. Gunji K, De-Bellis A, Kubota S, Swanson X, Wengrowicz S, Cochran B, Ackrell B, Salvi M, Bellastela A, Bizzarre A, Sinisi A, Wall J 1998 Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive and specific markers for eye muscle autoimmunity in patients with Graves' hyperthyroidism. Submitted